USA | DC | DISTRICT OF COLUMBIA COUNTY | WASHINGTON | 20847
Health And Human Services, Department Of- Food And Drug Administration- Fda Office Of Acquisitions And Grants Services
FY26 FDA Broad Agency Announcement ( BAA) for Advanced Research and Development of Regulatory Science - Please see attachment. 53 total awards from the subject announcment.
Advanced Research and Development of Regulatory Science Machine learning- guided 3D nanoprinting of retinal vascular phantom library, patient- derived digital twin platform for breast cancer imaging, automated insulin delivery interoperability framework, supporting rural clinical investigator readiness, virtual subject matter expert agents for radiology report evaluation, susceptibility guidance for daptomycin and enterococcus species, high- throughput physiology tool for NAMs- based safety studies, long- term vascular MPS to assess cyclic cardiovascular toxicity of oncology drugs, mechanistic gastric NAM and PBPK framework for bioequivalence of oral peptide drug products, NAM- aligned pediatric glioblastoma CIVM, validated TIM based mechanistic platforms, multiscale digital twin framework for flexible biomanufacturing, risk- based digital design of pharmaceutical manufacturing systems, microwave- assisted lyophilization, advanced control techniques for lyophilization, targeted polymer- lipid nanoparticle pla
AI helper
FDA Broad Agency Announcement (BAA) for advanced research and development of regulatory science. 53 total awards. Awards are made to various institutions and companies for research projects in areas such as medical devices, pharmaceuticals, biologics, and public health preparedness. Contract numbers, amounts, and awardee information are listed. The announcement includes multiple research areas: modernizing development and evaluation of FDA-regulated products, strengthening postmarket surveillance, and invigorating public health preparedness and response.